Biogen Inc DEFA14A, filed Apr 20, 2020

Biogen Inc. (BIIB)

DEFA14A 2020-04-20

Added on October 18, 2026


☐		Preliminary Proxy Statement

☐		Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐		Definitive Proxy Statement

☒		Definitive Additional Materials

☐		Soliciting Material Pursuant to §240.14a-12



☒	No fee required.

☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

	1)	Title of each class of securities to which transaction applies:
	2)	Aggregate number of securities to which transaction applies:
	3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	4)	Proposed maximum aggregate value of transaction:
	5)	Total fee paid:

☐	Fee paid previously with preliminary materials.

☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

	1)	Amount Previously Paid:
	2)	Form, Schedule or Registration Statement No.:
	3)	Filing Party:
	4)	Date Filed:


	Meeting Information
BIOGEN INC.	Meeting Type: For holders as of:		Annual Meeting April 6, 2020
	Date: June 3, 2020 Time: 9:00 a.m. Eastern Time
	Location:	Meeting live via the Internet-please visit www.virtualshareholdermeeting.com/BIIB2020.
	The company will be hosting the meeting live via the Internet this year. To attend the meeting via the Internet please visit www.virtualshareholdermeeting.com/BIIB2020 and be sure to have the information that is printed in the box marked by the arrow (located on the following page).
BIOGEN INC. 225 BINNEY STREET CAMBRIDGE, MA 02142	You are receiving this communication because you hold shares in the company named above. This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting.

	See the reverse side of this notice to obtain proxy materials and voting instructions.


Proxy Materials Available to VIEW or RECEIVE:
2020 NOTICE AND PROXY STATEMENT				2019 ANNUAL REPORT WITH FORM 10-K

How to View Online: Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com.

How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

	1)	BY INTERNET:	www.proxyvote.com
	2)	BY TELEPHONE:	1-800-579-1639
	3)	BY E-MAIL*:	sendmaterial@proxyvote.com

* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow (located on the following page) in the subject line.

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 20, 2020 to facilitate timely delivery.


	Vote By Internet:
	Before The Meeting:
	Go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.

	During The Meeting:
	Go to www.virtualshareholdermeeting.com/BIIB2020. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.

	Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.


	Voting Items

	The Board recommends a vote FOR the following proposals:

	1.	Election of Directors. To elect the twelve director nominees numbered 1a through 1l to serve for a one-year term extending until the 2021 annual meeting of stockholders and their successors are duly elected and qualified.













	1k. Stephen A. Sherwin

	1l. Michel Vounatsos

2.	To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2020.

3.	Say on Pay - To approve an advisory vote on executive compensation.

		Before You Vote
		Before You Vote

		How To Vote
		How To Vote